Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-audited Financial (both Standalone & Consolidated) Results of the Company for the quarter & half year ended 30.09.2026.

'i.'S icagen An 1SO 9001:2015 Company Date: October 28, 2026 BSE Limited, Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 BSE Scrip Code: 533014 Dear Sir/Madam, Sub: Intimation of Date of Board Meeting under Regulation 29 of SEBI (LODR) Regulations, 2015 This is to inform you that, a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 224 November, 2026 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & Half year ended 30t September, 2026. As intimated earlier as per our letter dated 28t September, 2026, the trading window for dealing in the Company’s equity shares by the Designated Persons & their immediate relatives will remain closed from 1st October, 2026 till 48 hours after the declaration of Un-audited Financial Results for the Quarter & Half year ended 30t September, 2026, as per Company’s Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015. The above intimation may kindly be taken on record. Thanking You, Yours sincerely, For Sicagen India Limited Digitally signed by ANKITA ANKITAJAIN Date: 2026.10.28 JA'N 16:34:55 +05'30" (Ankita Jain) Company Secretary Sicagen India Ltd. Registered & Corporate Office: 4™ Floor, Spic House, 88, Mount Road, Guindy, Chennai 600 032 INDIA Tel: +91 44 4075 4075 | Fax: +91 44 4075 4099 | info@sicagen.com CIN.: L74900TN2004PLC053467 | wwiw.sicagen.com